glutathione sarcoidosis of the Skin (Cutaneous Sarcoidosis) — Foundation for Sarcoidosis Research Sarcoidosis: Evaluation and Treatment |

10.1161/CIRCULATIONAHA.106.638460 [DOI] [PubMed] [Google Scholar] Cardenas-Rodriguez N., Huerta-Gertrudis B., Rivera Espinosa L., Montesinos-Correa H., Bandala C., Carmona-Aparicio L., et al

Results TNBS Depletes GSH and Generates ROS In Vitro Although, the induction of colitis by TNBS administration is a well defined model of IBD commonly used to uncover pathophysiological factors, the interaction between GSH and TNBS, remains unknown

Be Consistent: Daily support is more effective than occasional high doses

doi: 10.1039/c3mt00364g

A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo

long-term safety unknown Glucagon Glucagon, a peptide, produced by A cells of the pancreatic islets of Langerhans Glucagon is arrived from a large precursor peptide (one intermediate: glicentin, 69-amino acid peptide) Rapidly inactivated in plasma (degraded also at hepatic, renal, and tissue receptor sites) Enteroglucagons: Glicentin immunoreactivity: cells of the small intestine, pancreatic A cells, pancreatic effluent-- glucagon-like peptides Glucagon: Pharmacological activity Metabolic: glucagon interacts with specific, hepatic receptors G protein activation, increase in adenylyl cyclase activity, increases cAMP production Increased catabolism of stored glycogen, increased gluconeogenesis, increased ketogenesis Pharmacological consequences: increased blood glucose, decreased hepatic glycogen insulin released from normal pancreatic B cells catecholamines from pheochromocytoma calcitonin from medullary carcinoma Cardiovascular Effects: positive inotropic action (increased myocardial contractility) positive chronotropic (increased heart rate) these effects mediated by cAMP Smooth Muscle Effects: (large doses): intestinal smooth muscle relaxation Management of Severe Hypoglycemic States emergency treatment in insulin-dependent unconscious patients in which intravenous glucose cannot be administered (a conscious patient would be treated by drinking orange juice or other high sugar content foods) Glucagon is available for parenteral use